(1) The instrumentation industry has huge market prospects
At present, the research and development and industrial development of scientific instruments in China have gradually come out of the trough and entered the stage of rapid development. Take China's medical device market as an example. In 2000, the market size was 45 billion yuan, and in 2004 it was 76 billion yuan. It is estimated that it will reach 100 billion yuan in 2010. Academician Jin said that it is worth mentioning that with the sustained and rapid growth of China's economy and the implementation of the national policy of “enterprise to become the main body of scientific and technological innovationâ€, the annual growth rate of China's instrumentation industry has exceeded 20% for four consecutive years.
(2) High-end instruments are controlled by foreign companies, and there is still a gap between the quality of domestically produced medium and low-grade instruments and the international
80% of China's CT market is divided by international giants such as GE, Siemens and Philips; ultrasonic instruments, Chinese companies only account for one-tenth of the market; testing instruments, Chinese companies only account for 4% of the total market; NMR instruments, Shenzhen Anke, Although Medit is counterattacking, most of the products are middle and lower-end products, which only account for 10% of the total market sales; ECG instruments, foreign companies account for 90% of the market share, of which high-end monitors account for 80%, multi-channel physiological recorders account for 90% %, sleep monitors account for 60%.
At present, we are limited to medium and low-end instruments. High-end instruments are basically held by foreign companies or have already been sent to China for holding. This situation is quite serious. For example, the gas chromatograph of Agilent in the United States is very shocking. Because Aglient has a lot of Market Engineers working outside, the company's internal Application Lab is 'facing' to your Chinese needs. This 'direction' shows: What do I need to do in China, SARS, coal mine safety testing, and now the doping test of the Olympics; Aglient's gas chromatography, which accounts for 70% of the world's sales, is not just for China, how do we Dealing with this situation is an urgent new issue.
(3) Famous foreign companies have come to China for investment and shareholding
Well-known foreign companies have come to China to invest and hold shares, such as Johnson & Johnson, Kodak, Hewlett-Packard, Roche, Pan Pacific, Siemens, Bayer, Philips, Oxford, Japan's Omron, Hitachi, Toshiba, etc. in medical equipment. In the analytical instrument, Shanghai Jingke and Aglient initially cooperated. The Chinese holding is 51%. However, after the opening of the Chinese market, it has been acquired by Aglient after expanding production and financing. Shanghai Jingke has a current value of 4% in Aglient.
There have also been cases in which a famous foreign company wants to participate in the general analysis of shares. Now many small analytical instrument manufacturers have shares of foreigners; some foreign companies are pervasive, not only occupying some high-end products, but actually have gone In the low-end market, this phenomenon is quite serious in the instrumentation industry.
(4) Problems with instrumentation components
The importance of instrumentation components is self-evident. There is still a lot of work to be done in this area in China. Currently, all CMOS phones in the market are imported, and all CCDs behind digital cameras are also bought abroad, not to mention TD-CCD for aerial cameras. The production of Delay CCD) shows the weak development of detector components in China.
(5) Foreign companies compete for talents and establish R&D centers in China
Next page
Threaded Pipe Flange,Flange With Threaded Hole,Forged Female Threaded Flange,Din Flange
Jinan Xintai Forging Co., Ltd , https://www.xtdzflange.com